AngioDynamics, Inc. (ANGO)
10.31
-1.63
(-13.65%)
USD |
NASDAQ |
Apr 02, 16:00
10.51
+0.20
(+1.94%)
After-Hours: 19:01
AngioDynamics Research and Development Expense (TTM) : 27.69M for Nov. 30, 2025
Research and Development Expense (TTM) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (TTM) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Research and Development Expense (TTM) Benchmarks
| Boston Scientific Corp. | 2.052B |
| Intuitive Surgical, Inc. | 1.312B |
| Masimo Corp. | 126.40M |
| InspireMD, Inc. | 15.00M |
| Plus Therapeutics, Inc. | 8.379M |